DB
TVRD

Danske Bank’s Tvardi Therapeutics TVRD Stock Holding History

Danske Bank’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$12 – 1482
2024
Q4 		$12 Buy
+1
New +$11 ﹤0.01% 1341

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Danske Bank's TVRD Position: Q1 2025 in Review

Danske Bank sold out of Tvardi Therapeutics (TVRD) in Q1 2025, closing a stake of 1 share — an estimated $12 sold.

Danske Bank first reported a position in TVRD in Q4 2024 and held it in 1 quarter. The position peaked at $12 in Q4 2024. 33 funds tracked by Wall St. Rank hold TVRD as of Q1 2025.

  • Danske Bank reported no remaining Tvardi Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Danske Bank sold 1 Tvardi Therapeutics share in Q1 2025, an estimated $12.
  • Danske Bank first reported a position in Tvardi Therapeutics in Q4 2024 and held it in 1 quarter.
  • Danske Bank's Tvardi Therapeutics position peaked at $12 in Q4 2024.
  • 33 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2025.

Based on Danske Bank's 13F filing for Q1 2025, filed 18 Dec 2025.